Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-26

Clinical Trial Update: Ischemic Post-conditioning in Acute Ischemic Stroke Thrombectomy (PROTECT-2) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial PROTECT-2 is evaluating ischemic post-conditioning during thrombectomy for acute ischemic stroke; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Capital Medical University | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING